These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

469 related items for PubMed ID: 17143314

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Management of osteoporosis due to ovarian failure.
    Eastell R.
    Med Pediatr Oncol; 2003 Sep; 41(3):222-7. PubMed ID: 12868123
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis.
    Brixen KT, Christensen PM, Ejersted C, Langdahl BL.
    Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):260-70. PubMed ID: 15228497
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of osteoporosis in octogenarians].
    Pepersack T.
    Rev Med Brux; 2008 Sep; 29(4):311-6. PubMed ID: 18949982
    [Abstract] [Full Text] [Related]

  • 8. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 6. Use of bisphosphonates in the treatment of osteoporosis.
    Hodsman A, Adachi J, Olszynski W.
    CMAJ; 1996 Oct 01; 155(7):945-8. PubMed ID: 8837544
    [Abstract] [Full Text] [Related]

  • 9. What is new in the treatment of steroid-induced osteoporosis?
    Liu RH, Werth VP.
    Semin Cutan Med Surg; 2007 Dec 01; 26(4):203-9. PubMed ID: 18395668
    [Abstract] [Full Text] [Related]

  • 10. Pathogenesis and management of primary osteoporosis.
    Bauwens SF, Drinka PJ, Boh LE.
    Clin Pharm; 1986 Aug 01; 5(8):639-59. PubMed ID: 3527528
    [Abstract] [Full Text] [Related]

  • 11. [Austrian guidance for the pharmacological treatment of osteoporosis in postmenopausal women--update 2009].
    Dimai HP, Pietschmann P, Resch H, Preisinger E, Fahrleitner-Pammer A, Dobnig H, Klaushofer K, Austrian Society for Bone and Mineral Research (AuSBMR).
    Wien Med Wochenschr Suppl; 2009 Aug 01; (122):1-34. PubMed ID: 19484202
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic options in osteoporosis.
    Dominguez LJ, Scalisi R, Barbagallo M.
    Acta Biomed; 2010 Aug 01; 81 Suppl 1():55-65. PubMed ID: 20518192
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The prevention and treatment of osteoporosis: a review.
    Cosman F.
    MedGenMed; 2005 May 11; 7(2):73. PubMed ID: 16369451
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Prevention of osteoporotic fracture by pharmaceutical interventions].
    Nakamura T.
    Clin Calcium; 2006 Dec 11; 16(12):1961-67. PubMed ID: 17142925
    [Abstract] [Full Text] [Related]

  • 19. The teriparatide in the treatment of severe senile osteoporosis.
    Manuele S, Sorbello L, Puglisi N, Grasso S, La Malfa L, D'Urbino G, Rizzotto M, Strano S, Maugeri D.
    Arch Gerontol Geriatr; 2007 Dec 11; 44 Suppl 1():249-58. PubMed ID: 17317460
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.